| Name | 2-benzyl-6-nitro-3,4-dihydro-1H-isoquinoline |
|---|---|
| Synonyms |
2-benzyl-6-nitro-1,2,3,4-tetrahydroisoquinoline
N-benzyl-6-nitro-1,2,3,4-tetrahydroisoquinoline N-benzyl-6-nitrotetrahydroisoquinoline |
| Density | 1.233±0.06 g/cm3(Predicted) |
|---|---|
| Boiling Point | 400.4±45.0 °C(Predicted) |
| Molecular Formula | C16H16N2O2 |
| Molecular Weight | 268.31000 |
| Exact Mass | 268.12100 |
| PSA | 49.06000 |
| LogP | 3.61420 |
| HS Code | 2933499090 |
|---|
|
~%
208589-95-1 |
| Literature: Pfizer Inc Patent: US6121283 A1, 2000 ; |
|
~96%
208589-95-1 |
| Literature: Johnson, Paul D.; Aristoff, Paul Adrian; Poel, Toni-Jo; Thomasco, Lisa Marie Patent: US2002/133021 A1, 2002 ; |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933499090 |
|---|---|
| Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |